What Can You Expect at the Nasal Formulation & Delivery Summit?
The 4th Nasal Formulation & Delivery Summit is uniting leaders across large pharma, biotechs, device developers and academia all advancing intranasal therapies across systemic, CNS, emergency-use, and infectious disease indications. This industry-focused meeting is built to tackle the formulation, delivery, and development challenges shaping today’s intranasal pipeline.
Across expert-led presentations, interactive workshops, and data-driven case studies, hear how teams from Eli Lilly, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, Nasus Pharma, and more are navigating drug–device integration, predictive preclinical and clinical translation, nose-to-brain delivery, regulatory pathways for combination products, investment strategy, and manufacturing scale-up. The agenda spans both liquid and powder-based approaches, with a strong emphasis on technical depth and future commercial readiness.
Join 70+ nasal experts to exchange best practices, build high-value connections, and leave with actionable strategies and partnerships to confidently accelerate your intranasal programs.
What to Expect?
Attending Companies Include